Seeing Is Believing
with an average price target of $2.72. This is a potential upside of $2.72 (0%) from yesterday's end of day stock price of $0.
Prevail Therapeutics's activity chart (see below) currently has 8 price targets and 4 ratings on display.
Analysts average stock forecasts to be materialized ratio is 80% with an average time for these price targets to be met of 173.33 days.
Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 23-Dec-2020. First documented stock forecast 15-Jul-2019.
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
22
$-1 (-4.35%)
22
3 years 3 months 5 days ago
2/5 (40%)
$-1.18 (-5.09%)
234
Buy
23
23
3 years 3 months 11 days ago
2/2 (100%)
$3.81 (25.20%)
83
Sell
20
$-3 (-13.04%)
3 years 7 months 17 days ago
3/3 (100%)
$5.53 (38.90%)
203
What is PRVL (Prevail Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on PRVL (Prevail Therapeutics) with a proven track record?
Which analyst has the current lower performing score on PRVL (Prevail Therapeutics) with a proven track record?
Which analyst has the most public recommendations on PRVL (Prevail Therapeutics)?
Which analyst is the currently most bullish on PRVL (Prevail Therapeutics)?
Which analyst is the currently most reserved on PRVL (Prevail Therapeutics)?